BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6976918)

  • 1. The role of complement in the function of the monocyte - macrophage system.
    Schorlemmer HU
    Haematol Blood Transfus; 1981; 27():59-71. PubMed ID: 6976918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of activated complement components on enzyme secretion by macrophages.
    Schorlemmer HU; Allison AC
    Immunology; 1976 Nov; 31(5):781-8. PubMed ID: 992710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement.
    Ezekowitz RA; Sim RB; MacPherson GG; Gordon S
    J Clin Invest; 1985 Dec; 76(6):2368-76. PubMed ID: 2934410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.
    Schorlemmer HU; Bitter-Suermann D; Allison AC
    Immunology; 1977 Jun; 32(6):929-40. PubMed ID: 328387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of complement by macrophages and modulation of their functions through complement activation.
    Hartung HP; Hadding U
    Springer Semin Immunopathol; 1983; 6(4):283-326. PubMed ID: 6364428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.
    Riches DW; Stanworth DR
    Immunology; 1981 Sep; 44(1):29-39. PubMed ID: 7275186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
    Schlesinger LS; Bellinger-Kawahara CG; Payne NR; Horwitz MA
    J Immunol; 1990 Apr; 144(7):2771-80. PubMed ID: 2108212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-dependent triggering of B-cells, T-cells and macrophages.
    Dierich MP; Erdei A; Gergely J; Myones BL; Schulz TF
    Behring Inst Mitt; 1987 Jun; (81):128-32. PubMed ID: 2957999
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased Fc and C3 receptor function in macrophage populations which are refractory to migration inhibitory factor, C3 activators, and immune complex.
    Leu RW; Hefley SM; Herriott MJ
    Cell Immunol; 1983 Aug; 80(1):31-42. PubMed ID: 6347401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible self-regulating mechanism mediated by C3b-acceptor-bound C3b generated by stimulated macrophages.
    Fábry Z; Erdei A; Gergely J
    Scand J Immunol; 1985 Nov; 22(5):549-55. PubMed ID: 2934802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of C3b as the major serum protein that stimulates prostaglandin and thromboxane synthesis by macrophages.
    Hsueh W; Arroyave CM; Jordan RL
    Prostaglandins; 1984 Dec; 28(6):889-904. PubMed ID: 6240667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway.
    Schorlemmer HU; Edwards JH; Davies P; Allison AC
    Clin Exp Immunol; 1977 Feb; 27(2):198-207. PubMed ID: 849651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis.
    Griffin FM; Mullinax PJ
    J Immunol; 1990 Jul; 145(2):697-701. PubMed ID: 2195117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.
    Kings M; Nydegger UE; de Weck AL
    Immunology; 1984 Jan; 51(1):123-31. PubMed ID: 6197357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA; Frank MM; Tenner AJ
    Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3bi/CR3 is a main ligand-receptor interaction in attachment and phagocytosis of C3-coated particles by mouse peritoneal macrophages.
    Kimura M; Griffin FM
    Scand J Immunol; 1992 Aug; 36(2):183-91. PubMed ID: 1502493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.